Oxylipin profiling in endothelial cells in vitro – Effects of DHA and hydrocortisone upon an inflammatory challenge
•Oxylipin profiles were measured in an in vitro model of endothelial inflammation.•TNFα/IL-1β triggered the COX pathway and the release of pro-inflammatory oxylipins.•DHA inhibited inflammatory pathways while turning on the pro-resolution program.•Hydrocortisone blunted the release of both inflammat...
Saved in:
Published in: | Prostaglandins & other lipid mediators Vol. 144; p. 106352 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Elsevier Inc
01-10-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •Oxylipin profiles were measured in an in vitro model of endothelial inflammation.•TNFα/IL-1β triggered the COX pathway and the release of pro-inflammatory oxylipins.•DHA inhibited inflammatory pathways while turning on the pro-resolution program.•Hydrocortisone blunted the release of both inflammatory and resolution oxylipins.
Omega-3 poly-unsaturated fatty acids have been shown to have beneficial effects on several inflammatory-driven endpoints such as cardiovascular diseases. The anti-inflammatory effects of docosahexaenoic acid (DHA) are largely mediated through various oxylipins. Yet, mechanistic insights are limited. Here, we measured 53 oxylipins using LC-MS/MS in an in vitro model of endothelial cell inflammation, and compared the changes induced by DHA to hydrocortisone, a well-established anti-inflammatory drug. DHA modified several oxylipins derived from different precursors such as DHA, AA, LA and EPA. In response to a TNFα and IL-1-β challenge, DHA clearly reduced many COX-derived pro-inflammatory oxylipins, yet to a minor extent when compared to hydrocortisone. DHA also upregulated metabolites from the CYP and LOX pathways as opposed to hydrocortisone. Thus, DHA reduced pro-inflammation and enhanced pro-resolution, while hydrocortisone blunted both the pro- and anti-inflammatory pathways. Our results may fuel further research on the mitigation of corticosteroids adverse side-effects. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1098-8823 |
DOI: | 10.1016/j.prostaglandins.2019.106352 |